Pooja Shukla

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (18)

• Supplementary Figures S1-S5 from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
  2025 DOI: 10.1158/2326-6066.30720985
  +Save
• Supplementary Figures S6-S10 from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
  2025 DOI: 10.1158/2326-6066.30720982
  +Save
• Supplementary Tables from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
  2025 DOI: 10.1158/2326-6066.30720979
  +Save
• Data from Microparticle-Delivered Cxcl9 Prolongs Braf Inhibitor Efficacy in Melanoma
  2025 DOI: 10.1158/2326-6066.c.6627970
  +Save
• Supplementary Tables from Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma
  2024 DOI: 10.1158/2326-6066.27026327.v1
  +Save
• Supplementary Tables from Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma
  2024 DOI: 10.1158/2326-6066.27026327
  +Save
• Supplementary Figures S6-S10 from Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma
  2024 DOI: 10.1158/2326-6066.27026330
  +Save
• Supplementary Figures S6-S10 from Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma
  2024 DOI: 10.1158/2326-6066.27026330.v1
  +Save
• Supplementary Figures S1-S5 from Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma
  2024 DOI: 10.1158/2326-6066.27026333
  +Save
• Supplementary Figures S1-S5 from Microparticle-delivered Cxcl9 prolongs Braf inhibitor efficacy in melanoma
  2024 DOI: 10.1158/2326-6066.27026333.v1
  +Save